Filing Details
- Accession Number:
- 0001209191-18-017179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 15:22:43
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-06 15:22:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184746 | N Daniel Gregoire | 55 Nod Road Avon CT 06001 | General Counsel And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 12,538 | $63.95 | 25,995 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 5,042 | $64.87 | 31,037 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 5,295 | $68.50 | 36,332 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2018-03-05 | 22,875 | $99.05 | 13,457 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2018-03-05 | 12,538 | $0.00 | 12,538 | $63.95 |
Common Stock | Stock Options (right to buy) | Disposition | 2018-03-05 | 5,042 | $0.00 | 5,042 | $64.87 |
Common Stock | Stock Options (right to buy) | Disposition | 2018-03-05 | 5,295 | $0.00 | 5,295 | $68.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-03-04 | No | 4 | X | Direct | |
5,041 | 2026-03-03 | No | 4 | X | Direct | |
10,590 | 2027-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $98.75 to $99.25, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Not applicable.
- The remainder of 5,041 options shall vest on March 3, 2019.
- The remainder of 10,590 options shall vest in equal increments on each of March 3 of 2019 and 2020.